News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,136 Results
Type
Article (31962)
Company Profile (58)
Press Release (365116)
Section
Business (112913)
Career Advice (1322)
Deals (24066)
Drug Delivery (94)
Drug Development (59721)
Employer Resources (104)
FDA (9953)
Job Trends (9085)
News (211677)
Policy (25524)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
Academia (1838)
Accelerated approval (1)
Adcomms (20)
Allergies (64)
Alliances (42267)
ALS (58)
Alzheimer's disease (1089)
Antibody-drug conjugate (ADC) (88)
Approvals (9957)
Artificial intelligence (146)
Autoimmune disease (14)
Automation (6)
Bankruptcy (236)
Best Places to Work (7696)
BIOSECURE Act (15)
Biosimilars (80)
Biotechnology (42)
Bladder cancer (45)
Brain cancer (25)
Breast cancer (173)
Cancer (1484)
Cardiovascular disease (119)
Career advice (1110)
Career pathing (19)
CAR-T (101)
Cell therapy (284)
Cervical cancer (15)
Clinical research (48102)
Collaboration (640)
Compensation (366)
Complete response letters (19)
COVID-19 (2471)
CRISPR (29)
C-suite (104)
Cystic fibrosis (56)
Data (1408)
Decentralized trials (1)
Denatured (9)
Depression (35)
Diabetes (202)
Diagnostics (3549)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (33)
Drug discovery (81)
Drug pricing (96)
Drug shortages (28)
Duchenne muscular dystrophy (76)
Earnings (40274)
Editorial (32)
Employer branding (13)
Employer resources (94)
Events (45634)
Executive appointments (291)
FDA (10734)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (442)
Gene editing (71)
Generative AI (12)
Gene therapy (220)
GLP-1 (671)
Government (4071)
Grass and pollen (3)
Guidances (34)
Healthcare (11448)
Huntington's disease (18)
IgA nephropathy (19)
Immunology and inflammation (79)
Indications (21)
Infectious disease (2600)
Inflammatory bowel disease (75)
Inflation Reduction Act (7)
Influenza (47)
Intellectual property (67)
Interviews (231)
IPO (10440)
IRA (40)
Job creations (1749)
Job search strategy (956)
Kidney cancer (7)
Labor market (15)
Layoffs (271)
Leadership (7)
Legal (7057)
Liver cancer (49)
Lung cancer (216)
Lymphoma (100)
Machine learning (4)
Management (32)
Manufacturing (204)
MASH (50)
Medical device (5921)
Medtech (5922)
Mergers & acquisitions (13988)
Metabolic disorders (557)
Multiple sclerosis (49)
NASH (20)
Neurodegenerative disease (64)
Neuropsychiatric disorders (22)
Neuroscience (1449)
NextGen: Class of 2025 (3662)
Non-profit (2773)
Northern California (1523)
Now hiring (4)
Obesity (319)
Opinion (190)
Ovarian cancer (52)
Pain (47)
Pancreatic cancer (63)
Parkinson's disease (103)
Partnered (12)
Patents (145)
Patient recruitment (55)
Peanut (38)
People (24883)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase I (14536)
Phase II (20896)
Phase III (16951)
Pipeline (814)
Podcasts (38)
Policy (101)
Postmarket research (1848)
Preclinical (6014)
Press Release (28)
Prostate cancer (73)
Psychedelics (28)
Radiopharmaceuticals (204)
Rare diseases (254)
Real estate (2584)
Recruiting (44)
Regulatory (16073)
Reports (22)
Research institute (1591)
Resumes & cover letters (195)
Rett syndrome (2)
RNA editing (3)
RSV (44)
Schizophrenia (59)
Series A (72)
Series B (38)
Service/supplier (4)
Sickle cell disease (37)
Southern California (1252)
Special edition (5)
Spinal muscular atrophy (137)
Sponsored (18)
Startups (1891)
State (1)
Stomach cancer (11)
Supply chain (47)
The Weekly (27)
United States (12478)
Vaccines (684)
Venture capitalists (24)
Webinars (5)
Weight loss (241)
Women's health (13)
Worklife (9)
Date
Today (152)
Last 7 days (497)
Last 30 days (1859)
Last 365 days (21527)
2025 (5182)
2024 (22368)
2023 (25277)
2022 (33434)
2021 (35937)
2020 (34146)
2019 (27960)
2018 (21270)
2017 (20212)
2016 (18718)
2015 (21513)
2014 (15966)
2013 (12889)
2012 (13639)
2011 (14418)
2010 (13095)
Location
Africa (569)
Alabama (29)
Alaska (3)
Arizona (87)
Arkansas (5)
Asia (25885)
Australia (4666)
California (3324)
Canada (1139)
China (339)
Colorado (144)
Connecticut (150)
Delaware (91)
Europe (62061)
Florida (501)
Georgia (120)
Hawaii (1)
Idaho (28)
Illinois (278)
India (21)
Indiana (181)
Iowa (6)
Japan (110)
Kansas (59)
Kentucky (15)
Louisiana (7)
Maine (27)
Maryland (615)
Massachusetts (2398)
Michigan (99)
Minnesota (131)
Mississippi (1)
Missouri (46)
Montana (20)
Nebraska (10)
Nevada (34)
New Hampshire (21)
New Jersey (1059)
New Mexico (15)
New York (1011)
North Carolina (485)
North Dakota (4)
Northern California (1523)
Ohio (108)
Oklahoma (6)
Oregon (10)
Pennsylvania (742)
Puerto Rico (4)
Rhode Island (12)
South America (795)
South Carolina (10)
South Dakota (1)
Southern California (1252)
Tennessee (52)
Texas (425)
Utah (75)
Virginia (84)
Washington D.C. (35)
Washington State (283)
West Virginia (2)
Wisconsin (27)
397,136 Results for "fresenius ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fresenius Receives FDA Approval for their Denosumab Biosimilars and Secures Global Settlement Agreement
March 27, 2025
·
4 min read
Press Releases
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi® (ustekinumab-aauz)
March 3, 2025
·
13 min read
Press Releases
Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic
February 10, 2025
·
5 min read
Press Releases
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum
March 13, 2025
·
4 min read
Business
Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board
Fresenius Medical Care has nominated six employee representatives as members of the company’s Supervisory Board.
February 5, 2024
·
3 min read
Press Releases
Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar
January 9, 2025
·
7 min read
Press Releases
Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO System
November 19, 2024
·
4 min read
Press Releases
Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio
December 17, 2024
·
6 min read
PatenSee and Fresenius Medical Care Sign Clinical Collaboration Agreement
PatenSee, developer of a fistula monitoring system for dialysis patients, has entered into an agreement with Fresenius Medical Care, a leading global provider of dialysis services.
February 13, 2024
·
2 min read
FDA
Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
Fresenius, via its operating company Fresenius Kabi, announced the immediate U.S. availability of Tyenne®, a biosimilar of Actemra®.
April 15, 2024
·
14 min read
1 of 39,714
Next
